Company Filing History:
Years Active: 2007-2012
Title: Craig Pigott: Innovator in Antibody Research
Introduction
Craig Pigott is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies directed to tumor necrosis factor.
Latest Patents
Craig Pigott holds 2 patents related to his innovative work. His latest patents include "Antibodies directed to tumor necrosis factor and uses thereof" and "Antibodies directed to the antigen TNFα and uses of such antibodies." These patents focus on fully human monoclonal antibodies directed to the antigen TNFα, along with nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules. His work also involves hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies.
Career Highlights
Craig Pigott is currently associated with Amgen Fremont Inc., where he continues to advance his research in antibody development. His work has the potential to impact therapeutic approaches for various diseases.
Collaborations
Some of his notable coworkers include John Stephen Babcook and Jaspal Singh Kang, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Craig Pigott's innovative work in antibody research exemplifies the importance of scientific advancements in biotechnology. His contributions are paving the way for new therapeutic solutions.